- Home
- / BRIM Biotechnology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
BRIM Biotechnology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
NT$43.8
2024-10-29
Market Capitalization
NT$5 B
2024-10-29
Revenue
NT$5.5 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 13, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| TWD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 90.8M | 360.0K | 526.0K | 90.0K | 333.0K | 5.5M |
| Cost of goods sold | 311.0K | 4.2M | ||||
| Gross profit | 92.2M | 4.6M | 550.0K | 92.0K | 27.0K | 1.3M |
| Gross profit margin, % | 101.6% | 1269.4% | 104.6% | 102.2% | 8.1% | 24.3% |
| Operating expense total | 242.4M | 89.8M | 214.9M | 688.8M | 335.6M | 411.1M |
| Depreciation and amortization | 3.8M | 3.8M | 4.0M | 5.4M | 9.2M | 43.1M |
| EBITDA | (159.8M) | (133.1M) | (277.0M) | (713.3M) | (362.6M) | (423.3M) |
| EBITDA margin, % | -176.0% | -36978.9% | -52653.8% | -792554.5% | -108876.3% | -7709.9% |
| EBIT | (114.8M) | (136.9M) | (280.9M) | (718.7M) | (371.8M) | (466.5M) |
| EBIT margin, % | -126.5% | -38040.8% | -53408.0% | -798548.9% | -111655.3% | -8497.5% |
| Interest income | 1.3M | 500.0K | 829.0K | 21.8M | 32.9M | 31.8M |
| Interest expense | 72.0K | 111.0K | 79.0K | 152.0K | 91.0K | 497.0K |
| Pre tax profit | (97.0M) | (105.4M) | (274.3M) | (688.0M) | (315.5M) | (450.9M) |
| Income tax expense | 9.1M | |||||
| Net Income | (106.1M) | (105.4M) | (274.3M) | (688.0M) | (315.5M) | (450.9M) |